Amongst the biomarkers, we found that the levels of IL-6 (p = 0.006) and uKIM-1 (p = 0.03) were significantly higher in those patients that presented with AKI, whilst the results for the uNGAL were significantly lower (p-value = 0.0002). The gene discussed is IL6; the disease is acute kidney injury.